Choudhury Rawshan, Diao Aipo, Zhang Fang, Eisenberg Evan, Saint-Pol Agnes, Williams Catrin, Konstantakopoulos Athanasios, Lucocq John, Johannes Ludger, Rabouille Catherine, Greene Lois E, Lowe Martin
Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom.
Mol Biol Cell. 2005 Aug;16(8):3467-79. doi: 10.1091/mbc.e05-02-0120. Epub 2005 May 25.
Oculocerebrorenal syndrome of Lowe is caused by mutation of OCRL1, a phosphatidylinositol 4,5-bisphosphate 5-phosphatase localized at the Golgi apparatus. The cellular role of OCRL1 is unknown, and consequently the mechanism by which loss of OCRL1 function leads to disease is ill defined. Here, we show that OCRL1 is associated with clathrin-coated transport intermediates operating between the trans-Golgi network (TGN) and endosomes. OCRL1 interacts directly with clathrin heavy chain and promotes clathrin assembly in vitro. Interaction with clathrin is not, however, required for membrane association of OCRL1. Overexpression of OCRL1 results in redistribution of clathrin and the cation-independent mannose 6-phosphate receptor (CI-MPR) to enlarged endosomal structures that are defective in retrograde trafficking to the TGN. Depletion of cellular OCRL1 also causes partial redistribution of a CI-MPR reporter to early endosomes. These findings suggest a role for OCRL1 in clathrin-mediated trafficking of proteins from endosomes to the TGN and that defects in this pathway might contribute to the Lowe syndrome phenotype.
洛氏眼脑肾综合征由OCRL1基因突变引起,OCRL1是一种定位于高尔基体的磷脂酰肌醇4,5-二磷酸5-磷酸酶。OCRL1的细胞功能尚不清楚,因此OCRL1功能丧失导致疾病的机制也不明确。在此,我们表明OCRL1与在反式高尔基体网络(TGN)和内体之间运作的网格蛋白包被转运中间体相关联。OCRL1直接与网格蛋白重链相互作用,并在体外促进网格蛋白组装。然而,OCRL1与膜的结合并不需要与网格蛋白相互作用。OCRL1的过表达导致网格蛋白和阳离子非依赖性甘露糖6-磷酸受体(CI-MPR)重新分布到扩大的内体结构中,这些结构在向TGN的逆行运输中存在缺陷。细胞内OCRL1的缺失也会导致CI-MPR报告基因部分重新分布到早期内体中。这些发现表明OCRL1在网格蛋白介导的从内体到TGN的蛋白质运输中发挥作用,并且该途径中的缺陷可能导致洛氏综合征表型。